332 related articles for article (PubMed ID: 11895119)
1. Chemistry and chemical biology of taxane anticancer agents.
Miller ML; Ojima I
Chem Rec; 2001; 1(3):195-211. PubMed ID: 11895119
[TBL] [Abstract][Full Text] [Related]
2. Overcoming multidrug resistance in taxane chemotherapy.
Geney R; Ungureanu lM; Li D; Ojima I
Clin Chem Lab Med; 2002 Sep; 40(9):918-25. PubMed ID: 12435109
[TBL] [Abstract][Full Text] [Related]
3. General and recent aspects of the chemistry and structure-activity relationships of taxoids.
Guéritte F
Curr Pharm Des; 2001 Sep; 7(13):1229-49. PubMed ID: 11472264
[TBL] [Abstract][Full Text] [Related]
4. Syntheses and structure-activity relationships of taxoids derived from 14 beta-hydroxy-10-deacetylbaccatin III.
Ojima I; Slater JC; Kuduk SD; Takeuchi CS; Gimi RH; Sun CM; Park YH; Pera P; Veith JM; Bernacki RJ
J Med Chem; 1997 Jan; 40(3):267-78. PubMed ID: 9022793
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of new antitumor taxoids. Effects of cyclohexyl substitution at the C-3' and/or C-2 of taxotere (docetaxel).
Ojima I; Duclos O; Zucco M; Bissery MC; Combeau C; Vrignaud P; Riou JF; Lavelle F
J Med Chem; 1994 Aug; 37(16):2602-8. PubMed ID: 7914541
[TBL] [Abstract][Full Text] [Related]
6. Medicinal chemistry and chemical biology of new generation taxane antitumor agents.
Ojima I; Geney R; Ungureanu IM; Li D
IUBMB Life; 2002; 53(4-5):269-74. PubMed ID: 12121008
[TBL] [Abstract][Full Text] [Related]
7. The solid state, solution and tubulin-bound conformations of agents that promote microtubule stabilization.
Jiménez-Barbero J; Amat-Guerri F; Snyder JP
Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):91-122. PubMed ID: 12678753
[TBL] [Abstract][Full Text] [Related]
8. Taxanes: a new class of antitumor agents.
Huizing MT; Misser VH; Pieters RC; ten Bokkel Huinink WW; Veenhof CH; Vermorken JB; Pinedo HM; Beijnen JH
Cancer Invest; 1995; 13(4):381-404. PubMed ID: 7627725
[TBL] [Abstract][Full Text] [Related]
9. Syntheses and biological activity of C-3'-difluoromethyl-taxoids.
Ojima I; Lin S; Slater JC; Wang T; Pera P; Bernacki RJ; Ferlini C; Scambia G
Bioorg Med Chem; 2000 Jul; 8(7):1619-28. PubMed ID: 10976509
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the new generation taxane anticancer agents.
Geney R; Chen J; Ojima I
Med Chem; 2005 Mar; 1(2):125-39. PubMed ID: 16787308
[TBL] [Abstract][Full Text] [Related]
11. [Taxoids: structural and experimental properties].
Lavelle F; Combeau C; Commerçon A
Bull Cancer; 1995 Apr; 82(4):249-64. PubMed ID: 10846536
[TBL] [Abstract][Full Text] [Related]
12. Quest for Efficacious Next-Generation Taxoid Anticancer Agents and Their Tumor-Targeted Delivery.
Ojima I; Wang X; Jing Y; Wang C
J Nat Prod; 2018 Mar; 81(3):703-721. PubMed ID: 29468872
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of docetaxel (Taxotere).
Lavelle F; Bissery MC; Combeau C; Riou JF; Vrignaud P; André S
Semin Oncol; 1995 Apr; 22(2 Suppl 4):3-16. PubMed ID: 7740328
[TBL] [Abstract][Full Text] [Related]
14. Effects of Taxotere on invasive potential and multidrug resistance phenotype in pancreatic carcinoma cell line SUIT-2.
Liu B; Staren E; Iwamura T; Appert H; Howard J
World J Gastroenterol; 2001 Feb; 7(1):143-8. PubMed ID: 11819752
[No Abstract] [Full Text] [Related]
15. [Chemical and biological studies on Taxol (Paclitaxel) and Taxotere (Docetaxel), new antineoplastic agents].
Guéritte-Voegelein F; Guénard D; Dubois J; Wahl A; Potier P
J Pharm Belg; 1994; 49(3):193-205. PubMed ID: 7914532
[TBL] [Abstract][Full Text] [Related]
16. Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP).
Vanhoefer U; Cao S; Harstrick A; Seeber S; Rustum YM
Ann Oncol; 1997 Dec; 8(12):1221-8. PubMed ID: 9496387
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in design, synthesis and bioactivity of paclitaxel-mimics.
Wen G; Qu XX; Wang D; Chen XX; Tian XC; Gao F; Zhou XL
Fitoterapia; 2016 Apr; 110():26-37. PubMed ID: 26906104
[TBL] [Abstract][Full Text] [Related]
18. Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells.
Ojima I; Slater JC; Michaud E; Kuduk SD; Bounaud PY; Vrignaud P; Bissery MC; Veith JM; Pera P; Bernacki RJ
J Med Chem; 1996 Sep; 39(20):3889-96. PubMed ID: 8831755
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the medicinal chemistry of taxoids with novel beta-amino acid side chains.
Ojima I; Lin S; Wang T
Curr Med Chem; 1999 Oct; 6(10):927-54. PubMed ID: 10519906
[TBL] [Abstract][Full Text] [Related]
20. Survival of docetaxel-resistant prostate cancer cells in vitro depends on phenotype alterations and continuity of drug exposure.
Makarovskiy AN; Siryaporn E; Hixson DC; Akerley W
Cell Mol Life Sci; 2002 Jul; 59(7):1198-211. PubMed ID: 12222966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
